Type 2 Diabetes

>

Latest News

Deepak Bhatt, MD, MPH | Credit: Mount Sinai Heart
Exploring the Impact of the Sotagliflozin Approval, with Deepak Bhatt, MD, MPH

May 27th 2023

Ahead of the sotagliflozin approval, Deepak Bhatt, MD, MPH, offers perspective into potential future research opportunities for the SGLT1/2 inhibitor and discusses the impact of a 3rd agent boasting SGLT2 inhibition receiving approval for heart failure.

US Food and Drug Adminstration logo in black over a white background | Credit: Food and Drug Administration
FDA Approves Sotagliflozin for Treatment of Heart Failure

May 26th 2023

Elizabeth Selvin, PhD, MPH | Credit: Johns Hopkins Medicine
Earlier Age at Diabetes Onset Confers Greater Risk of Dementia Later in Life

May 25th 2023

Phase 2b Trial Suggests Efficacy of Oral Danuglipron for Glycemic Control in T2D
Phase 2b Trial Suggests Efficacy of Oral Danuglipron for Glycemic Control in T2D

May 24th 2023

Kris Kowley, MD | Credit: MJH Life Sciences
GLP-1 for NASH? A Hepatologist's Perspective on Current Data

May 16th 2023

Video Series
Video Interviews
Podcasts
Thumbnailor Diabetes Dialogue podcast featuring the podcast logo and headshots of Diana. Isaacs, PharmD, and Natalie Bellini, DNP
Thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of Diana Isaacs, PharmD, and Natalie Bellini, DNP
Logo for Diabetes Dialogue podcast
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue
Diabetes Dialogue thumbnail
Diabetes Dialogue Square Thumbnail
Stuart Weinzimer, MD (Courtesy: Yale Medicine)
Grazia Aleppo, MD
Joanne Rinker, MS, RDN (Courtesy: Twitter)

More News

© 2023 MJH Life Sciences

All rights reserved.